Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.

Kelley MC, Gupta RK, Hsueh EC, Yee R, Stern S, Morton DL
J Clin Oncol. 2001 19 (4): 1176-82

PMID: 11181684 · DOI:10.1200/JCO.2001.19.4.1176

MeSH Terms (7)

Antigens, Neoplasm Female Humans Male Melanoma Neoplasm Recurrence, Local Survival Rate

Connections (1)

This publication is referenced by other Labnodes entities: